First Trust Nasdaq Pharmaceuticals ETF Rating $29.18 +0.26 (+0.88%) Closing price 10/17/2025 03:50 PM EasternExtended Trading$29.20 +0.02 (+0.07%) As of 10/17/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.51Holdings in FTXH have an aggregate rating of Moderate Buy based on 487 analyst ratings issued in the past year covering 25 companies (86.1% of the portfolio).FTXH Aggregate Price Target$29.19High Prediction$29.19Average Prediction$29.19Low Prediction$29.19Holdings in FTXH have an aggregate price target of $29.19 and a range of $29.19 to $29.19 covering 25 companies (86.1% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.61%ABBVAbbVie$229.66+1.2%4.6833 of 5 stars2.74$234.05 1.9%27Trending NewsAnalyst ForecastAnalyst Revision7.56%PFEPfizer$24.52+1.2%4.9508 of 5 stars2.39$28.13 14.7%18Trending News7.28%JNJJohnson & Johnson$193.27+0.6%4.8473 of 5 stars2.74$199.88 3.4%23Trending NewsEarnings ReportDividend AnnouncementAnalyst Revision7.25%MRKMerck & Co., Inc.$84.78+1.0%4.9993 of 5 stars2.30$104.33 23.1%20Trending News6.59%BMYBristol Myers Squibb$43.63+0.5%4.97 of 5 stars2.35$57.23 31.2%20Trending News4.06%BIIBBiogen$143.00+0.5%4.7475 of 5 stars2.32$180.69 26.4%31Trending NewsAnalyst Revision3.92%LLYEli Lilly and Company$803.53-1.9%4.9765 of 5 stars2.67$939.12 16.9%24Trending NewsGap Down3.55%CAHCardinal Health$156.29+2.0%4.8001 of 5 stars2.80$166.00 6.2%15Positive News3.54%AMGNAmgen$298.81+1.0%4.5463 of 5 stars2.32$305.50 2.2%19Positive NewsAnalyst Upgrade3.53%REGNRegeneron Pharmaceuticals$578.05+1.6%4.8345 of 5 stars2.79$817.88 41.5%29Positive News3.53%VRTXVertex Pharmaceuticals$416.81+2.0%4.8759 of 5 stars2.62$494.38 18.6%29Positive News3.47%UTHRUnited Therapeutics$433.34+0.2%4.6504 of 5 stars2.67$457.21 5.5%153.41%GILDGilead Sciences$122.81+4.2%4.8774 of 5 stars2.86$119.17 -3.0%28Trending NewsAnalyst ForecastInsider TradeHigh Trading Volume3.30%VTRSViatris$10.17+0.7%3.0387 of 5 stars1.86$11.17 9.8%73.20%ZTSZoetis$144.15+0.6%4.8629 of 5 stars2.44$196.71 36.5%92.24%JAZZJazz Pharmaceuticals$136.06+1.3%4.5893 of 5 stars2.76$178.93 31.5%17Positive News1.74%ILMNIllumina$95.46-0.5%4.8288 of 5 stars2.11$115.25 20.7%191.60%PTCTPTC Therapeutics$65.95-1.3%3.2829 of 5 stars2.53$69.00 4.6%15Analyst Revision1.50%INCYIncyte$87.57+0.3%4.5394 of 5 stars2.32$84.79 -3.2%19Analyst Downgrade1.49%CRLCharles River Laboratories International$178.37+2.0%4.45 of 5 stars2.35$181.29 1.6%17Analyst Forecast1.37%EXELExelixis$39.25+0.1%4.6888 of 5 stars2.63$44.42 13.2%241.21%MEDPMedpace$528.07+1.3%4.4315 of 5 stars1.94$430.60 -18.5%17Positive NewsUpcoming EarningsAnalyst Forecast1.11%BMRNBioMarin Pharmaceutical$53.29+0.6%4.9643 of 5 stars2.55$93.26 75.0%221.09%ELANElanco Animal Health$21.42+4.4%2.567 of 5 stars2.91$19.14 -10.6%110.90%HALOHalozyme Therapeutics$67.03+0.2%4.8552 of 5 stars2.42$73.00 8.9%12Positive News This page (NASDAQ:FTXH) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
